A Literature Review of Management on Radiodermatitis
![]() |
Kwon, Mi Hye
(Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Yoon, Jee-Hyun (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong) Kim, Eun Hye (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong) Lee, Jee Young (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong) Yoon, Seong Woo (Department of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong) |
1 | Lee SE, Lew W. A case of radiation recall dermatitis which developed in a patient with Kaposi sarcoma. Korean J Dermatol 46(8):1141-1144, 2008 |
2 | Wei J, Meng L, Hou X, Qu C, Wang B, Xin Y, Jiang X. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res 11:167-177, 2018. DOI |
3 | Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TTT, Truong P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26(13):2085-2092, 2008 DOI |
4 | Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D, Hornsby R. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 90(4):748-755, 2014 DOI |
5 | Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol 4(2):78-82, 1992 DOI |
6 | Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 58(3):333-339, 2001 DOI |
7 | Theberge V, Harel F, Dagnault A. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial. Int J Radiat Oncol Biol Phys 75(4):1048-1052, 2009 DOI |
8 | O'Donovan A, Coleman M, Harris R, Herst P. Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA. Eur J Cancer Care (Engl) 24(3):425-435, 2015 DOI |
9 | Leventhal J, Young MR. Radiation dermatitis: Recognition, prevention, and management. Oncology (Williston Park) 31(12):885-899, 2017 |
10 | Chan RJ, Webster J, Chung, B, Marquart L, Ahmed M, Garantziotis S. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 14(53), 2014. |
11 | Burch SE, Parker SA, Vann AM, Arazie JC. Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys 38(2):447-451, 1997 DOI |
12 | Bennett C. An investigation into the use of a non-metallic deodorant during radiotherapy treatment: a randomised controlled trial. J Radiother Prac 8(1):3-9, 2009 DOI |
13 | Gee A, Churn M, Errington RD. A randomised controlled trial to test a non-metallic deodorant used during a course of radiotherapy. J Radiother Prac 1(4):205-212, 2000 DOI |
14 | Niazi TM, Vuong T, Azoulay L, Marijnen C, Bujko K, Nasr E, Lambert C, Duclos M, Faria S, David M, Cummings B. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study. Int J Radiat Oncol Biol Phys 84(3):e305-e310, 2012 DOI |
15 | Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol 81(2) :558-67, 2019 DOI |
16 | Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, Arnold BB, Porinchak M, Lacouture M, McCormick B, Powell SN, Gelblum DY. A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys 101(2): 325-333, 2018 DOI |
17 | Haruna F, Lipsett A, Marignol L. Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis. Anticancer Res 37(10):5343-5353, 2017 |
18 | Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J. Double-blind, randomised clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42(2):155-161, 1997 DOI |
19 | Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089-1094, 2012 DOI |
20 | Kirova YM, Fromantin I, de Ricke Y, Fourquet A, Movan E, Padiglione S, Ealcou MC, Campana F, Bollet MA. Can we decrease the skin reaction in breast cancer patients using hyluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol 100(2):205-209, 2011 DOI |
21 | Ghasemi A, Ghashghai Z, Akbari J, Yazdani-Charati J, Salehifar E, Hosseinimehr SJ. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial. Eur J Clin Pharmacol 75(2):171-178, 2019 DOI |
22 | Elliott EA, Wright JR, Swann RS, Nguyen-Tân F, Takita C, Bucci MK, Garden AS, Kim H, Hug EB, Ryu J, Greenberg M, Saxton JP, Ang K, Berk L. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol 24(13):2092-2097, 2006 DOI |
23 | Wells M, Macmillan M, Raab G, MacBride S, Bell N, MacKinnon K, MacDougall H, Samuel L, Munro A. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol 73(2):153-162, 2004 DOI |
24 | Freedman GM, Radiation complications and their management, 716-725, In The Breast, Elsevier, 2018 |
25 | Kouvaris JR, Kouloulias VE, Plataniotis GA, Kokakis JD, Vlahos LJ. Topical granulocyte-macrophage colonystimulating factor for radiation dermatitis of the vulva. Br J Dermatol 144(3):646-647, 2001 DOI |
26 | Hemati S, Asnaashari O, Sarvizadeh M, Motlagh BN, Akbari M, Tajvidi M, Gookizadeh A. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer 20(8): 1613-1618, 2012 DOI |
27 | Chan RJ, Blades R, Jones L, Downer TR, Peet SC, Button E, Wyld D, McPhail S, Doolan M, Yates P. A single-blind, randomised controlled trial of StrataXRT(R) - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol 139;72-78, 2019 DOI |
28 | Kang HC, Ahn SD, Choi DH, Kang MK, Chung WK, Wu HG. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiat Oncol J 32(3):156-162, 2014 DOI |
29 | Pommier P, Gomez F, Sunyach MP, D’'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22(8):1447-1453, 2004 DOI |
30 | Scalia S, Marchetti N, Bianchi A. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight. Molecules 18(1): 574-587, 2013 DOI |
31 | Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, Li X, Meng X, Kong L, Xing L, Yu J. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. Br J Radiol 89(1058): 20150665, 2016 DOI |
32 | Ferreira EB, Ciol MA, Vasques CI, Bontempo Pde S, Vieira NN, Silva LF, Avelino SR, Dos Santos MA, Dos Reis PE. Gel of chamomile vs. urea cream to prevent acute radiation dermatitis in patients with head and neck cancer: a randomized controlled trial. J Adv Nurs. 72(8):1926-1934, 2016 DOI |
33 | Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36(2):345-349, 1996 DOI |
34 | Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25(6):442-451, 2002 DOI |
35 | Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, Asrari F, Pilepich MV, Gagnon JD, Wong G. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation- induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48(5):1307-1310, 2000 DOI |
36 | Maiche AG, Grohn P, Maki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30(3):395-397, 1991 DOI |
37 | Geara FB, Eid T, Zouain N, Thebian R, Andraos T, Chehab C, Ramia P, Youssef B, Zeidan YH. Randomized, prospective, open label phase III trial comparing Mebo ointment with Biafine cream for the management of acute dermatitis during radiotherapy for breast cancer. Am J Clin Oncol 41(12):1257-1262, 2018 DOI |
38 | Kong M, Hwang DS, Lee JY, Yoon SW. The efficacy and safety of Jaungo, a traditional medicinal ointment, in preventing radiation dermatitis in patients with breast cancer: a prospective, single-blinded, randomized pilot study. Evid Based Complement Alternat Med 2016:9481413, 2016 |
![]() |